Simplifying Global Compliance
FDAnews Drug Daily Bulletin
BioSyent Pharma Signs Exclusive Licensing and Distribution Agreement for Two New Drug Products
Aug. 20, 2012
BioSyent announced that its subsidiary BioSyent Pharma has signed an exclusive licensing and distribution agreement with a European partner for two new products that will be marketed by its hospital products division. The products will be launched after Health Canada approval.
Copyright ©2018. All Rights Reserved.
Design, CMS, Hosting & Web Development :: ePublishing